Well-known medtech executives discussed the potential impact of specific policy changes that may be implemented under the Trump administration.
As medtech companies reported their quarterly earnings over the past month, executives were asked repeatedly about the potential impact of specific changes that may come out of Washington, D.C. This includes the possibility of “repeal and replace” of the Affordable Care Act, a border tax, corporate repatriation, and other issues.
Read on to learn what the biggest names in the medtech industry are saying about these potential changes.
[Image courtesy of PUBLICDOMAINPICTURES/PIXABAY]